Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
Gholamreza Bidkhori, Rui Benfeitas, Martina Klevstig, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 50
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Saranya Chidambaranathan Reghupaty, Paul B. Fisher, Devanand Sarkar
Advances in cancer research (2020), pp. 1-61
Open Access | Times Cited: 630
An atlas of human metabolism
Jonathan L. Robinson, Pınar Kocabaş, Hao Wang, et al.
Science Signaling (2020) Vol. 13, Iss. 624
Open Access | Times Cited: 334
Computational network biology: Data, models, and applications
Chuang Liu, Yifang Ma, Jing Zhao, et al.
Physics Reports (2019) Vol. 846, pp. 1-66
Open Access | Times Cited: 181
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 127
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
Charlotte K.Y. Ng, Eva Dazert, Tuyana Boldanova, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 106
Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 96
Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 63
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Lactate Drives Senescence-Resistant Lineages in Hepatocellular Carcinoma via Histone H2B Lactylation of NDRG1
Lu Li, Jinyun Dong, Chunwei Xu, et al.
Cancer Letters (2025), pp. 217567-217567
Closed Access | Times Cited: 2
Update on hepatocellular carcinoma: Pathologists’ review
Tony El Jabbour, Stephen M. Lagana, Hwajeong Lee
World Journal of Gastroenterology (2019) Vol. 25, Iss. 14, pp. 1653-1665
Open Access | Times Cited: 135
The Redox architecture of physiological function
Jérôme Santolini, Stephen A. Wootton, Alan A. Jackson, et al.
Current Opinion in Physiology (2019) Vol. 9, pp. 34-47
Open Access | Times Cited: 119
Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review
Bo Hu, Jianzhen Lin, Xiaobo Yang, et al.
Cell Proliferation (2020) Vol. 53, Iss. 3
Open Access | Times Cited: 109
The complexity of the serine glycine one-carbon pathway in cancer
Miguel Reina‐Campos, María T. Diaz‐Meco, Jorge Moscat
The Journal of Cell Biology (2019) Vol. 219, Iss. 1
Open Access | Times Cited: 97
Cellular heterogeneity and plasticity in liver cancer
Lo‐Kong Chan, Yu‐Man Tsui, Daniel Wai‐Hung Ho, et al.
Seminars in Cancer Biology (2021) Vol. 82, pp. 134-149
Open Access | Times Cited: 96
Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers
Tian‐Jian Yu, Ding Ma, Yingying Liu, et al.
Molecular Therapy (2021) Vol. 29, Iss. 7, pp. 2350-2365
Open Access | Times Cited: 87
Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis – Part 2: Acetate and ACSS2 in Health and Disease
John R. Moffett, Narayanan Puthillathu, Ranjini Vengilote, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 86
A paradigm shift in medicine: A comprehensive review of network-based approaches
Federica Conte, Giulia Fiscon, Valerio Licursi, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2019) Vol. 1863, Iss. 6, pp. 194416-194416
Closed Access | Times Cited: 81
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Xinpeng Yin, Ruiyuan Xu, Jianlu Song, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1234-1256
Open Access | Times Cited: 64
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity
Jinguan Lin, Longzheng Xia, Linda Oyang, et al.
Oncogene (2022) Vol. 41, Iss. 7, pp. 1024-1039
Open Access | Times Cited: 61
Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma
Binghua Li, Yunzheng Li, Huajun Zhou, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 289-306
Open Access | Times Cited: 34
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 33
Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC
Shengnan Li, Han Xia, Zeyu Wang, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1079-1091
Open Access | Times Cited: 32
Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment
Ling Zhang, Bing-Zhong Zhai, Yuejin Wu, et al.
Drug Delivery (2023) Vol. 30, Iss. 1, pp. 1-18
Open Access | Times Cited: 29
Integrating Omics Data in Genome-Scale Metabolic Modeling: A Methodological Perspective for Precision Medicine
Partho Sen, Matej Orešič
Metabolites (2023) Vol. 13, Iss. 7, pp. 855-855
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top